Informational Only · Not Medical Advice · Consult a Dermatologist · Editorial Policy

The 2026 Oral Probiotic and Topical Secretome Acne Trial Protocol: What Researchers Still Need to Learn for People With Acne-Prone Skin

The 2026 oral probiotic and topical secretome acne trial protocol still needs to learn whether adding gut and skin biotics to standard care improves mild-to-moderate acne and restores gut bacteria. Topical secretome, a cell-derived mixture from mesenchymal stem cells, is tested here as a skin treatment alongside oral probiotics. The protocol runs for 8 weeks in 64 patients with mild-to-moderate acne vulgaris, as described in the trial protocol published by BMJ Open. It measures both acne severity and faecal microbiome change before and after treatment.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Table of Contents

What exactly is being tested?

The trial has four parallel arms. Everyone continues standard acne therapy and also receives active probiotic plus placebo secretome, placebo probiotic plus active secretome, both actives, or double placebo, according to the PubMed record from the U.S. National Library of Medicine.

All participants have acne severity checks and faecal microbiome tests at baseline and after therapy. The paired tests aim to link skin improvement with gut-skin axis effects. The short timeline keeps the focus narrow. With only 8 weeks, researchers can capture early lesion change and microbiome signals during active use.

Why combine an oral probiotic with a skin secretome?

The idea is to act on two sites at once. Oral probiotics target the gut, while secretome is applied to the skin where breakouts form. The protocol describes the combination as working through skin-microbiome modulation, reduced inflammation, and reduced pathogenic bacterial colonization and biofilm.

In plain terms, the goal is calmer skin with fewer acne-linked microbes and less clog-prone buildup. That dual approach matters for acne-prone skin because oil, dead skin, bacteria, and inflammation interact. A treatment that only dries oil may leave microbial and inflammatory triggers in place.

What did earlier probiotic studies find?

Earlier human work gives reason to run a larger adjunct trial, but not to expect a cure. Twice-daily topical live lactobacilli reduced inflammatory lesions and comedones and lowered Staphylococcus relative abundance without changing overall skin-microbiome diversity, as reported in the Cell Reports Medicine report from Cell Press. A separate 4-week prospective placebo-controlled study, NCT03605108, found oral spore-based probiotics improved total, inflammatory, and noninflammatory lesion counts and shifted gut microbiota, with a trend toward lower sebum.

Less sebum can mean less fuel for clogged pores, but a trend is not proof. Together, those results support short-term lesion and microbiome signals. They do not show lasting clearance, prevention of relapse, or safety across larger groups.

What should you do while researchers wait for results?

Keep using prescribed treatment. The new trial tests probiotics and secretome only on top of continued standard therapy, so it does not support stopping retinoids, benzoyl peroxide, or antibiotics to try biotics alone.

Use these practical steps while the evidence is pending: The key limit is size and time. With only 64 participants and 8 weeks of observation, the protocol can show short-term adjunct efficacy and microbiome signals but cannot establish long-term clearance, relapse, or rare safety events.

  • Stay on your current prescription unless your own prescriber changes it.
  • Track breakouts, irritation, missed doses, and new products for 2 to 4 weeks.
  • Bring that log to your dermatology visit before adding a probiotic or secretome product.

You Might Also Like

We use cookies to run this site, measure how it’s used, and show ads. Choose “Essentials only” to limit cookies to what the site needs to work. Privacy Policy.